Nine Chapters Capital Management’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q3	$90K	Buy	+2,093	New	+$90K	0.2%	126
2015 Q2	–	Sell	-3,453	Closed	-$1.44M	–	990
2015 Q1	$1.44M	Buy	+3,453	New	+$1.44M	0.12%	243